CD44 expression in normal, hyperplastic, and malignant endometrium

Journal of Pathology

Volumn 184, Issue 3, 1998, Pages 297-306

  Saegusa, Makoto ^a   Hashimura, Miki ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD44s; CD44v3; CD44v6; Endometrial carcinoma; Endometrial hyperplasia; ER; Menstrual cycle; PR

Indexed keywords

ESTROGEN RECEPTOR; HERMES ANTIGEN; MESSENGER RNA; PROGESTERONE RECEPTOR;

ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ANTIGENS, CD44; ANTIGENS, NEOPLASM; BLOTTING, SOUTHERN; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MENSTRUAL CYCLE; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0031939549     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199803)184:3<297::AID-PATH995>3.0.CO;2-7     Document Type: Article

References (36)

1. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cell 1991; 3: 347-350.
2. Underbill C. CD44: the hyaluronan receptor. J Cell Sci 1992; 103: 293-298.
3. Forsberg UH, Ala-Kapee MM, Jalkanen S, Andersson LC, Schroder J. The gene for human lymphocyte homing receptor is located on chromosome 11. Ear J Immunol 1989; 19: 409-412.
4. Brown TA, Bouchard T, St John T, Wayner E, Carter WG. Human keratinocytes express a new CD44 core protein (CD44E) as a heparinsulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 1991; 113: 207-221.
5. Jackson DG, Buckle J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992; 267: 4732-4739.
6. Hofmann M, Rudy W, Zoller M, et al. A new variant of glycoprotein CD44 splice variants confer metastatic behavior in rat: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51: 5292-5297.
7. Rudy W, Hofmann M, Schwartz-Albeiz R, et al. Two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 1993; 53: 1262-1268.
8. Reber S, Matzku S, Gunthert H, Ponta P, Herrlich P, Zoller M. Retardation of metastatic tumor growth after immunisation with metastasis-specific monoclonal antibodies. Int J Cancer 1990; 46: 919-927.
9. Sy MS, Guo YJ, Stamenkovic I. Distinct effect of two CD44 isoforms on tumor growth in vivo. J Exp Med 1991; 174: 859-866.
10. Thomas L, Byers HR, Vink J, Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substance. J Cell Biol 1992; 118: 971-977.
11. Mathew J, Hines JE, Obafunwa JO, Burr AW, Toole K, Burt AD. CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J Puthol 1996; 179: 74-79.
12. Imazeki F, Yokosuka O, Yamaguchi T, Ohio M, Isono K, Omata M. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans. Gastroenterology 1996; 110: 362-368.
13. Ermak G, Gerasimov G, Troshina K, et al. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid. Cancer Res 1995; 55: 4594-4598.
14. Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer 1993; 71: 1467-1470.
15. Behzad F, Seif MW, Campbell S, Aplin JD. Expression of two isoforms of CD44 in human endometrium. Biol Reprod 1994; 51: 739-747.
16. Fujita N, Yaegashi N, Ide Y, et al. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res 1994; 54: 3922-3928.
17. Creasman WT. Announcement, FIGO stages: 1988 revisions. Gynecol Oncol 1989; 35: 125-127.
18. Zaino RJ, Kurman R, Herbold D, et al. The significance of squamous differentiation in endometrial carcinoma: data from a gynecologic oncology group study. Cancer 1991; 68: 2293-2302.
19. Saegusa M, Kamata Y, Isono M, Okayasu I. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas. J Pathol 1996; 180: 275-282.
20. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340: 1053-1058.
21. Robbins M, McKinney M. Transcriptional regulation of neuromodulin (GAP-43) in mouse neuroblastoma clone N1E-115 as evaluated by the RT-PCR method. Mol Brain Res 1992; 13: 83-92.
22. Gotley DC, Fawcett J, Walsh MD, Reeder JA, Simmons DL, Antalis TM. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer 1996; 74: 342-351.
23. Gompel A, Sabourin JC, Martin A, et al. Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 1994; 144: 1195-1202.
24. Invin JC, Utian WH, Eckert RL. Sex steroids and growth factors differentially regulate the growth and differentiation of cultured human endometrial stromal cells. Endocrinology 1991; 129: 2385-2392.
25. Herold-Mende C, Seiter S, Born A, et al. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 1996; 179: 66-73.
26. Terpe HJ, Koopmann R, Imhof BA, Gunthert U. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol 1994; 174: 89-100.
27. Wielenga VJM, Heider K-H, Offerhaus GJA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 53: 4754-4756.
28. Gross J, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 1994; 54: 4238-4242.
29. Kallakury BVS, Yang F, Smith KE, et al Decreased levels of CD44 protein and mRNA in prostate carcinoma. Cancer 1996; 78: 1461-1469.
30. Sugino T, Gorham H, Yoshida K, et al. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Puthol 1996; 149: 873-882.
31. Deligdisch L, Cohen CJ, Histologie correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer 1985; 56: 1452-1455.
32. Matsumura Y, Sugiyama M, Matsumura S, et al. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 1995; 177: 11-20.
33. Dali P, Heider K-H, Sinn H-P, et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 1995; 60: 471-477.
34. Terris B, Flejou JF, Dubois S, et al. Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours. J Clin Pathol: Mol Pathol 1996; 49: M203-M208.
35. Woodman AC, Sugiyama M, Yoshida K, et al. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am J Pathol 1996; 149: 1519-1530.
36. Gorham H, Sugino T, Woodman AC, Tarin D. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa. J Clin Pathol 1996; 49: 482-488.